Variant report
Variant | nsv609885 |
---|---|
Chromosome Location | chr8:4637653-4643872 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:3)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:3 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | MYC | chr8:4639951-4640056 | MCF10A-Er-Src | breast: | n/a | n/a |
2 | STAT3 | chr8:4639708-4640284 | MCF10A-Er-Src | breast: | n/a | n/a |
3 | TEAD4 | chr8:4638549-4638953 | H1-hESC | embryonic stem cell: | n/a | n/a |
No data |
No data |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
PAICSP4 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs4875380 | chr8:4637653-4637654 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs115794529 | chr8:4637659-4637660 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs544981804 | chr8:4637665-4637666 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs4875117 | chr8:4637667-4637668 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
5 | rs557083693 | chr8:4637674-4637675 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs549601226 | chr8:4637684-4637685 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs552649543 | chr8:4637726-4637727 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs566473213 | chr8:4637738-4637739 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs142804866 | chr8:4637750-4637751 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs187080770 | chr8:4637764-4637765 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs191910480 | chr8:4637768-4637769 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs535146286 | chr8:4637776-4637777 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs538663660 | chr8:4637789-4637790 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs17071319 | chr8:4637797-4637798 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs150338392 | chr8:4637802-4637803 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs534624903 | chr8:4637808-4637809 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs80238679 | chr8:4637810-4637811 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs80180207 | chr8:4637817-4637818 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs373716361 | chr8:4637822-4637823 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs117244594 | chr8:4637823-4637824 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs576712017 | chr8:4637840-4637841 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs138041777 | chr8:4637854-4637855 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs183389117 | chr8:4637882-4637883 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs531037621 | chr8:4637898-4637899 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs376458696 | chr8:4637903-4637904 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs149528478 | chr8:4637923-4637924 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs185652381 | chr8:4637924-4637925 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs4875381 | chr8:4637927-4637928 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
29 | rs577887797 | chr8:4637932-4637933 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs369575772 | chr8:4637933-4637934 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs142711514 | chr8:4637937-4637938 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs33942979 | chr8:4637938-4637939 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs144171110 | chr8:4637957-4637958 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs201373046 | chr8:4637960-4637961 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs550640197 | chr8:4637962-4637963 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs568833798 | chr8:4637975-4637976 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs139804009 | chr8:4637994-4637995 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs4875382 | chr8:4638014-4638015 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
39 | rs4875383 | chr8:4638038-4638039 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
40 | rs113966184 | chr8:4638041-4638042 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs146212003 | chr8:4638045-4638046 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs75391275 | chr8:4638047-4638048 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs78513637 | chr8:4638058-4638059 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs529451910 | chr8:4638078-4638079 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs531860179 | chr8:4638085-4638086 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs11305573 | chr8:4638098-4638099 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs570666122 | chr8:4638105-4638106 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs11305572 | chr8:4638122-4638123 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs537701571 | chr8:4638142-4638143 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs139148932 | chr8:4638166-4638167 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Prostate cancer | 16573809 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
abnormal development | 18461090 | CNVD |
Crohn''s disease | 19220326 | CNVD |
Psoriasis | 19220326 | CNVD |
Prostate cancer | 21965145 | CNVD |
Prostate cancer | 18515986 | CNVD |
Chronic obstructive pulmonary disease | 20378733 | CNVD |
Autism | 18414403 | CNVD |
Cancer | 21183584 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Breast cancer | 17603634 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Cervical cancer | 17311676 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Schizophrenia | 20877625 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Breast cancer | 17001317 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Heart disease | 21282601 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Colorectal cancer | 21297112 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Breast cancer | 17133270 | CNVD |
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Breast cancer | 17393978 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Cancer | 21637783 | CNVD |
Breast cancer | 20837533 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Cancer | 22429812 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Breast cancer | 21264507 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Oral cancer | 21386901 | CNVD |
Prostate cancer | 21088497 | CNVD |
Breast cancer | 20940404 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Gastric cancer | 17167181 | CNVD |
Prostate cancer | 16705090 | CNVD |
8p-syndrome | 17576883 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
Lung adenocarcinoma | 19525976 | CNVD |
Lung cancer | 19525976 | CNVD |
Prostate cancer | 17245344 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Cancer | 16751803 | CNVD |
Wilms tumour | 21544195 | CNVD |
Gastric cancer | 17908304 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Breast cancer | 21785460 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Ductal carcinoma | 22052326 | CNVD |
Breast cancer | 21509527 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Epilepsy | 22083797 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21858162 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Autism | 22495311 | CNVD |
Congenital diaphragmatic hernia | 21064195 | CNVD |
Breast cancer | 21364760 | CNVD |
Cancer | 20164920 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Prostate cancer | 17217626 | CNVD |
Developmental delay | 19128483 | CNVD |
Neuroticism | 17667963 | CNVD |
Leukoplakia | 24403051 | CNVD |
Intellectual disability | 22045946 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Breast cancer | 16608533 | CNVD |
Seminomas | 18059402 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Lung cancer | 18438408 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Colorectal cancer | 22014273 | CNVD |
Lung squamous cell carcinoma | 22363434 | CNVD |
Cancer | 20164919 | CNVD |
Non-syndromic sensorineural hearing loss | 17289997 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Tetralogy of Fallot | 22912587 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:4631600-4638800 | Weak transcription | Brain Angular Gyrus | brain |
2 | chr8:4636600-4639000 | Enhancers | Ganglion Eminence derived primary cultured neurospheres | brain |
3 | chr8:4636800-4638000 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
4 | chr8:4637000-4637800 | Enhancers | Rectal Smooth Muscle | rectum |
5 | chr8:4637000-4638000 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
6 | chr8:4637000-4638000 | Enhancers | Brain Cingulate Gyrus | brain |
7 | chr8:4637000-4638600 | Enhancers | Fetal Kidney | kidney |
8 | chr8:4637000-4639000 | Enhancers | Cortex derived primary cultured neurospheres | brain |
9 | chr8:4637200-4637800 | Enhancers | Fetal Brain Male | brain |
10 | chr8:4637200-4638000 | Enhancers | Foreskin Melanocyte Primary Cells skin01 | Skin |
11 | chr8:4637200-4638000 | Enhancers | Colon Smooth Muscle | Colon |
12 | chr8:4637200-4639000 | Enhancers | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
13 | chr8:4637400-4638000 | Enhancers | Fetal Stomach | stomach |
14 | chr8:4637600-4638800 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
15 | chr8:4638000-4638400 | Weak transcription | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
16 | chr8:4638000-4639000 | Weak transcription | Foreskin Melanocyte Primary Cells skin01 | Skin |
17 | chr8:4638000-4639200 | Weak transcription | Foreskin Melanocyte Primary Cells skin03 | Skin |
18 | chr8:4638000-4639600 | Weak transcription | Brain Cingulate Gyrus | brain |
19 | chr8:4638400-4639000 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
20 | chr8:4638800-4639400 | Enhancers | Brain Angular Gyrus | brain |
21 | chr8:4639000-4640800 | Weak transcription | Cortex derived primary cultured neurospheres | brain |
22 | chr8:4639000-4641000 | Weak transcription | Ganglion Eminence derived primary cultured neurospheres | brain |
23 | chr8:4639200-4639400 | Enhancers | Foreskin Melanocyte Primary Cells skin01 | Skin |
24 | chr8:4639400-4640600 | Weak transcription | Brain Angular Gyrus | brain |
25 | chr8:4639600-4639800 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
26 | chr8:4639600-4639800 | Enhancers | Brain Cingulate Gyrus | brain |
27 | chr8:4640600-4640800 | Enhancers | Brain Angular Gyrus | brain |
28 | chr8:4640800-4641400 | Enhancers | Cortex derived primary cultured neurospheres | brain |
29 | chr8:4641000-4641200 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
30 | chr8:4641000-4641400 | Enhancers | Ganglion Eminence derived primary cultured neurospheres | brain |